Wednesday, July 8, 2026

pharma · Severe, Refractory Systemic Lupus Erythematosus · Refractory Progressive Multiple Sclerosis · AUTL

Autolus

News and analysis for Autolus on NovaPharmaNews — regulatory, clinical, and market coverage.

Munich, Bayern 81377, DE HQ
117 Employees
Public company Type
AUTL · NYSE Ticker
Company details
Status
Public
HQ
Munich, Bayern 81377, DE
Employees
117
Programs
16
Drugs
17
Patents
49
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Autolus — regulatory, clinical, and market coverage.

News and analysis for Autolus on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Autolus yet.

Back to company overview →